Last reviewed · How we verify
NCT03661021: Sante-Fe
Study of the Ability of a New Technique to Effectively Diagnose Movement Disorders
trial in Functional Movement Disorder in 40 participants. Completed in 22 July 2024.
22 July 2024
Quick facts
| Lead sponsor | The Cleveland Clinic |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 18 July 2018 |
| Primary completion | 22 July 2024 |
| Estimated completion | 22 July 2024 |
| Sites | 1 location across United States |
Conditions studied
- Functional Movement Disorder — all drugs for Functional Movement Disorder →
Sponsor
The Cleveland Clinic
Who can join
Eligibility, any sex, with Functional Movement Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Sante Fe is an investigation of a new technique to distinguish between different types of movement disorders, specifically organic versus functional, by observing changes in involuntary movements in two different situations.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03661021
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Functional Movement Disorder
Currently open trials in the same condition.
- NCT07588282 — The Effect of Psychoeducational Diagnosis Communication on Perception of Illness, Satisfaction, and Behavioral Intention · NA · recruiting
- NCT06393439 — Virtual Reality in Functional Movement Disorder · NA · recruiting
- NCT06257069 — Tremor Retrainer Software Application for Functional Tremor · NA · recruiting
- NCT06361615 — Effect of a Dual-task Intervention Program on Physical and Cognitive Function · NA · active not recruiting
- NCT05155059 — Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders · Phase 2 · active not recruiting
Other The Cleveland Clinic trials
Trials by the same sponsor.
- NCT07218198 — Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension · NA · not yet recruiting
- NCT07442747 — Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS · NA · not yet recruiting
- NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
- NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
- NCT07363343 — Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03661021 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Cleveland Clinic
- Last refreshed: 13 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03661021.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing